An EY expert on today’s life sciences M&A boom

Hannah Langworth 18 December 2018

EY's Bridget Walsh explores the drivers behind the recent spate of life sciences transactions and how dealmakers can package these in the most efficient way.

Next article »

« Previous article

Related Articles

Continuation funds shine as sponsors crave liquidity – Houlihan Lokey

25/03/24

Comment: PE taps into flourishing wealth management sector

25/03/24

In conversation: Kerry Baldwin, IQ Capital

13/03/24

IWD: Helen Steers, Pantheon Ventures

08/03/24

In conversation: Future Business Partnership’s founders discuss achieving B Corp status

07/03/24

CEE Report 2024: Forging a partnership

09/02/24

Search